吉法酯 AHFS /Drugs.com 國際藥品名稱 ATC碼
(2E )-3,7-dimethylocta-2,6-dien-1-yl (4E ,8E )-5,9,13-trimethyltetradeca-4,8,12-trienoate
CAS號 51-77-4 Y PubChem CID ChemSpider UNII KEGG ChEMBL CompTox Dashboard (EPA ) ECHA InfoCard 100.000.111 化學式 C 27 H 44 O 2 摩爾質量 400.637 g/mol 3D模型（JSmol
CC(C)=CCC/C(C)=C/CC/C(C)=C/CCC(=O)OC/C=C(C)/CCC=C(C)C
InChI=1S/C27H44O2/c1-22(2)12-8-14-24(5)16-10-17-25(6)18-11-19-27(28)29-21-20-26(7)15-9-13-23(3)4/h12-13,16,18,20H,8-11,14-15,17,19,21H2,1-7H3/b24-16+,25-18+,26-20+
N Key:ZPACYDRSPFRDHO-ROBAGEODSA-N
N
吉法酯 （英語：Gefarnate ，或譯為合歡香葉酯 ）是一種用於治療胃及十二指腸潰瘍 的藥物[ 1] 乾眼症 [ 2] [ 3]
^ Ohta Y, Kobayashi T, Imai Y, Inui K, Yoshino J, Nakazawa S. Effect of gefarnate on acute gastric mucosal lesion progression in rats treated with compound 48/80, a mast cell degranulator, in comparison with that of teprenone . Biol. Pharm. Bull. August 2005, 28 (8): 1424–30 [2019-12-20 ] . PMID 16079487 doi:10.1248/bpb.28.1424 存檔 於2019-08-30）. ^ Peral A, Domínguez-Godínez CO, Carracedo G, Pintor J. Therapeutic targets in dry eye syndrome. Drug News Perspect. April 2008, 21 (3): 166–76. PMID 18560615 ^ Gipson IK, Hori Y, Argüeso P. Character of ocular surface mucins and their alteration in dry eye disease . Ocul Surf. April 2004, 2 (2): 131–48 [2019-12-20 ] . PMID 17216084 doi:10.1016/s1542-0124(12)70149-0 原始內容 存檔於2020-05-20）.
